| Home > Publications database > Refining the clinical utility of [177Lu]Lu/[225Ac]Ac-PSMA tandem RLT in patients with metastatic castration resistant prostate cancer. > Access to Fulltext |
s00259-025-07632-1
|
|||||||
| version 1 |
| ||||||